Comment by rusk

3 months ago

> competition

We don’t need competition in insulin production. It is a know quantity with fixed and closed quality parameters. Fix the price and let suppliers compete on cost.

The problem in USA is that producing insuline is so regulated that setting up and maintaining production is obnoxiously expensive.

Note that if you cause by regulation or stupid laws something to be expensive to produce/import and then make it illegal to sell above that price - then you will get shortages.

As noone will want to produce insuline if required paperwork costs more than it's selling price.

Note that even if currently adding more regulation to solve problems caused by more regulation will not cause it, it may happen in future.

US healthcare regulations are on Nth round of that.

  • > setting up and maintaining production is obnoxiously expensive.

    This is what I meant by compete on cost. The manufacturers that are best at cutting these costs will make the most profit. That’s where competition should be focused on such generic items.

    • None of this is while insulin is so expensive in the US. None of it.

      We've been producing insulin for 100 years now. You guys are just making things up and it's wild.

      I don't think a single person who is claiming that regulation is driving up insulin prices has even Googled it to make sure what they're saying makes sense. Spoiler alert: It's not.

      The cost of insulin is a result of monopolies, pharmacy benefit managers, patents, and most importantly: a LACK of regulation on drug prices.

  • > The problem in USA is that producing insuline is so regulated that setting up and maintaining production is obnoxiously expensive.

    i don’t buy it. no other oecd nation has insulin prices as absurd as the us. this is a greed problem.

    the only people to blame when the government starts producing insulin will be the pharmaceutical companies and their refusal to be decent members of society. if they were even a tiny fraction more decent they wouldn’t be in the mess they’re directly causing.

    far too often companies are directly to blame for regulation as they repeatedly absolutely refuse to self-regulate and be decent pieces of society.

    • Greed explains nothing. People will be greedy when they are incentivized to be greedy, and thrifty when they are incentivized to be thrifty. There are plenty of incentives, I might add, for regulators to be greedy though.

  • > The problem in USA is that producing insuline is so regulated that setting up and maintaining production is obnoxiously expensive.

    This has absolutely nothing to do with insulin costs. Nada. Zip. Nil.

    > As noone will want to produce insuline if required paperwork costs more than it's selling price.

    Where are you getting this information from? I've been in the industry for a bit now and this is a first for me. That the reason why insulin is so expensive in the US is because it costs money to make????

There are many kinds of insulin variants on the market. The easy way to differentiate them is by release rate and duration. Gone in an hour for some and 24hours for others. There are other factors as well that make them incompatible with each other.

  • All clearly categorised and regulated. Fill the boxes and ship em and STFU

Nothing has fixed and closed quality parameters. At least not if your concern is quality as understood by the people who want or need insulin as opposed to whatever arbitrary standard a bureaucrat could make up.

  • > whatever arbitrary standard a bureaucrat

    You do know these people are scientific experts and have teams of scientific experts working for them, right. It’s not some blazing skulls stuffed shirt lol

    • No amount of scientific expertise will turn a subjective thing (which is what product quality is) into an objective thing. Credible, ethical, and well-trained scientists should be able to recognize that and desist from dressing up their preferences into scientific dress and passing it off as the results of objective science.

      4 replies →

That would ensure that it is extremely unlikely we get innovation in insulin production as it removes the financial incentive to take the risk with innovation.